Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Molecular and Cellular Cardiology
|
April 29, 2021
Protein acetylation in cardiac aging
Ashley Francois, Alessandro Canella, Lynn M Marcho, et al.
Journal for Immunotherapy of Cancer
|
January 7, 2026
Tumor-infiltrating microbes and therapy response: a new frontier in triple-negative breast cancer precision oncology
Lynn M Marcho, Karthik B Chakravarthy, Sachin R Jhawar, et al.
Frontiers in Oncology
|
April 10, 2025
Potent estrogen receptor β agonists with inhibitory activity <i>in vitro</i>, fail to suppress xenografts of endocrine-resistant cyclin-dependent kinase 4/6 inhibitor-resistant breast cancer cells
Lynn M Marcho, Christopher C Coss, Menglin Xu, et al.
Life Sciences
|
March 14, 2022
Molecular signature of cardiac remodeling associated with Polymerase Gamma mutation
Matthew W Gorr, Ashley Francois, Lynn M Marcho, et al.
Biorxiv : the Preprint Server for Biology
|
January 31, 2024
Potent Estrogen Receptor β Agonists with Inhibitory Activity <i>In Vitro</i> , Fail to Suppress Xenografts of Endocrine-Resistant Cyclin-dependent Kinase 4/6 inhibitor-Resistant Breast Cancer Cells
Lynn M Marcho, Christopher C Coss, Menglin Xu, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Sertad4 regulates pathological cardiac remodeling
Ashley Francois, Oscar Bermeo-Blanco, Ba Thong Nguyen, et al.
Cancer Biology & Therapy
|
March 27, 2025
Sulfatase 2 inhibition sensitizes triple-negative breast cancer cells to paclitaxel through augmentation of extracellular ATP
Jasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
Breast Cancer Research : BCR
|
November 7, 2024
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer
Jasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 2025
The elucidation of species-specific receptor pharmacology: A case study using subtype-selective para- and meta-carborane estrogen receptor agonists
Adeoluwa A Adeluola, Hanna S Radomska, Tyler A Wilson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 27, 2024
<b>The elucidation of species-specific receptor pharmacology: a case study using subtype selective </b>
Adeoluwa A Adeluola, Hanna S Radomska, Tyler A Wilson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Molecular and Cellular Cardiology
|
April 29, 2021
Protein acetylation in cardiac aging
Ashley Francois, Alessandro Canella, Lynn M Marcho, et al.
Journal for Immunotherapy of Cancer
|
January 7, 2026
Tumor-infiltrating microbes and therapy response: a new frontier in triple-negative breast cancer precision oncology
Lynn M Marcho, Karthik B Chakravarthy, Sachin R Jhawar, et al.
Frontiers in Oncology
|
April 10, 2025
Potent estrogen receptor β agonists with inhibitory activity <i>in vitro</i>, fail to suppress xenografts of endocrine-resistant cyclin-dependent kinase 4/6 inhibitor-resistant breast cancer cells
Lynn M Marcho, Christopher C Coss, Menglin Xu, et al.
Life Sciences
|
March 14, 2022
Molecular signature of cardiac remodeling associated with Polymerase Gamma mutation
Matthew W Gorr, Ashley Francois, Lynn M Marcho, et al.
Biorxiv : the Preprint Server for Biology
|
January 31, 2024
Potent Estrogen Receptor β Agonists with Inhibitory Activity <i>In Vitro</i> , Fail to Suppress Xenografts of Endocrine-Resistant Cyclin-dependent Kinase 4/6 inhibitor-Resistant Breast Cancer Cells
Lynn M Marcho, Christopher C Coss, Menglin Xu, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Sertad4 regulates pathological cardiac remodeling
Ashley Francois, Oscar Bermeo-Blanco, Ba Thong Nguyen, et al.
Cancer Biology & Therapy
|
March 27, 2025
Sulfatase 2 inhibition sensitizes triple-negative breast cancer cells to paclitaxel through augmentation of extracellular ATP
Jasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
Breast Cancer Research : BCR
|
November 7, 2024
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer
Jasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 2025
The elucidation of species-specific receptor pharmacology: A case study using subtype-selective para- and meta-carborane estrogen receptor agonists
Adeoluwa A Adeluola, Hanna S Radomska, Tyler A Wilson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 27, 2024
<b>The elucidation of species-specific receptor pharmacology: a case study using subtype selective </b>
Adeoluwa A Adeluola, Hanna S Radomska, Tyler A Wilson, et al.
Page
of 1